Carcinoma of the hypopharynx is uncommon, accounting for 4% of all malignancies of the
head and neck reported by the National Cancer Data Base and 7% of all malignancies of …

Squamous cell carcinoma of the hypopharynx represents a distinct clinical entity. Most
patients present with significant comorbidities and advanced‐stage disease. The overall …

OBJECTIVES: Squamous cell carcinoma (SCC) of the hypopharynx represents a distinct
clinical entity among other cancers of the head and neck region. Despite recent advances in …

Background Hypopharyngeal carcinoma is relatively rare, representing approximately 3% of
all head and neck malignancies. It also is characterized by having one of the worst …

The optimal therapy for hypopharyngeal carcinoma depends on its staging. For early-stage
disease, radiotherapy and surgery achieve similar results. Radical surgery followed by …

It is not uncommon for patients with hypopharyngeal cancer to present at an advanced stage
of disease. Surgical treatment provides a cure for the tumour with immediate relief from …

Squamous cell carcinoma of the hypopharynx remains a highly lethal disease. This article
documents our experience with 132 patients undergoing surgical management of squamous …

This best practice article reviews the published evidence on the pathology and patterns of
spread of carcinomas of the hypopharynx, and the relevance of pathological features to …

Cancer of the hypopharynx is relatively rare and accounts for roughly 3% of all head and
neck cancers. Unfortunately, hypopharyngeal carcinoma has one of the worst prognosis of …

Patients with squamous cell carcinoma of the hypopharynx (HPSCC) are often seen in
advanced stages and have a poor prognosis. The authors analysed 104 patients who had …